Every 10-Q that Synergy CHC Corp. (SNYR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SNYR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SNYR filings page.
Synergy CHC Corp. reported a Q1 2026 net loss of $2,568,899, compared with net income of $876,264 a year earlier, as revenue declined and interest costs rose. Revenue fell to $5,492,705 from $8,170,534, mainly due to lower nutraceutical and online sales and the absence of prior-year license revenue.
Gross margin remained high at 72% but dollar gross profit dropped to $3,970,795. Operating expenses increased to $4,537,915, driven by higher salaries, professional fees and stock-based compensation. Interest expense nearly doubled to $2,012,121, reflecting the new $17,500,000 term loan and receivables advances.
At March 31, 2026, cash was $292,115 with total assets of $6,461,591 versus total liabilities of $31,866,841, leaving a stockholders’ deficit of $25,405,250. Management evaluated going concern and concluded it expects to meet obligations over the next year, but leverage and liquidity remain tight.
Synergy CHC Corp. reported Q3 2025 results. Revenue was $8,010,112 versus $7,126,333 a year ago as shipments normalized after 2024 packaging changes. Gross profit rose to $5,680,816 with a 71% margin (from 67%). Net income was $125,327 compared to $783,593 in Q3 2024, reflecting higher operating and interest costs.
For the first nine months of 2025, revenue was $24,315,642 (vs. $24,563,036), and net income increased to $2,474,827 (vs. $2,019,309). Cash was $1,006,489 and total assets $20.69M at September 30, 2025. Total liabilities were $28.94M, and stockholders’ deficit improved to $(8.25)M.
The company refinanced with a $17.5M term loan at Term SOFR + 8.5% maturing in 2029, repaid legacy debts (including $10.0M to a shareholder-lender) and recorded debt settlement gains. In August 2025, it completed an IPO, issuing 1,750,000 shares for net proceeds of $3,880,462. Shares outstanding were 11,251,853 as of November 12, 2025.
Synergy CHC Corp. (SNYR) delivered higher profitability in the second quarter of 2025 while executing material debt refinancing. Revenue for the three months ended June 30, 2025 totaled $8,134,996, including $1,400,000 of license revenue, producing gross profit of $6,238,605. Net income after tax was $1,473,237 for the quarter ($2,349,501 for the six months), driving basic and diluted EPS of $0.17 for the quarter and $0.27 for the six months. Total assets were $19,726,346 with cash and restricted cash of $1,558,561. Total liabilities were $32,105,546, and stockholders' deficit improved to $(12,379,200). In May 2025 the company drew a $17.5 million term loan (with a $2.5 million delayed draw) and used proceeds to repay and restructure prior indebtedness, record a $2,154,522 gain on settlement of notes payable, issue pre-funded warrants and shares in partial debt settlements, and record related debt discounts and issuance costs. Management reported a working capital surplus of $12,383,132 and concluded these actions alleviate substantial doubt about the company’s ability to continue as a going concern for the next twelve months.